ATE315556T1 - Verfahren zur herstellung eines thiazol-ppar- liganden sowie dessen polymorphe - Google Patents

Verfahren zur herstellung eines thiazol-ppar- liganden sowie dessen polymorphe

Info

Publication number
ATE315556T1
ATE315556T1 AT02747330T AT02747330T ATE315556T1 AT E315556 T1 ATE315556 T1 AT E315556T1 AT 02747330 T AT02747330 T AT 02747330T AT 02747330 T AT02747330 T AT 02747330T AT E315556 T1 ATE315556 T1 AT E315556T1
Authority
AT
Austria
Prior art keywords
polymorphs
thiazole
producing
ppar ligand
compound
Prior art date
Application number
AT02747330T
Other languages
German (de)
English (en)
Inventor
Thierry Boyer
Caroline Jane Day
Andrew Jonathan Whitehead
Richard Anthony Henson
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of ATE315556T1 publication Critical patent/ATE315556T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
AT02747330T 2001-05-31 2002-05-29 Verfahren zur herstellung eines thiazol-ppar- liganden sowie dessen polymorphe ATE315556T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0113232.3A GB0113232D0 (en) 2001-05-31 2001-05-31 Chemical process

Publications (1)

Publication Number Publication Date
ATE315556T1 true ATE315556T1 (de) 2006-02-15

Family

ID=9915637

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02747330T ATE315556T1 (de) 2001-05-31 2002-05-29 Verfahren zur herstellung eines thiazol-ppar- liganden sowie dessen polymorphe

Country Status (22)

Country Link
US (1) US7244849B2 (cg-RX-API-DMAC7.html)
EP (1) EP1395572B1 (cg-RX-API-DMAC7.html)
JP (1) JP2004532265A (cg-RX-API-DMAC7.html)
KR (1) KR20040007631A (cg-RX-API-DMAC7.html)
CN (1) CN1551871A (cg-RX-API-DMAC7.html)
AT (1) ATE315556T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002317764B2 (cg-RX-API-DMAC7.html)
BR (1) BR0209892A (cg-RX-API-DMAC7.html)
CA (1) CA2448101A1 (cg-RX-API-DMAC7.html)
CO (1) CO5540298A2 (cg-RX-API-DMAC7.html)
CZ (1) CZ20033256A3 (cg-RX-API-DMAC7.html)
DE (1) DE60208682T2 (cg-RX-API-DMAC7.html)
ES (1) ES2256493T3 (cg-RX-API-DMAC7.html)
GB (1) GB0113232D0 (cg-RX-API-DMAC7.html)
HU (1) HUP0400117A3 (cg-RX-API-DMAC7.html)
IL (1) IL158641A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA03010943A (cg-RX-API-DMAC7.html)
NO (1) NO20035313L (cg-RX-API-DMAC7.html)
NZ (1) NZ529486A (cg-RX-API-DMAC7.html)
PL (1) PL367114A1 (cg-RX-API-DMAC7.html)
WO (1) WO2002096893A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200308570B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7105551B2 (en) * 2000-12-20 2006-09-12 Smithkline Beecham Corporation Thiazole derivatives for treating PPAR related disorders
CN1662487A (zh) 2002-06-19 2005-08-31 伊莱利利公司 酰胺连接基过氧化物酶体增殖物激活受体调节剂
TW200400816A (en) 2002-06-26 2004-01-16 Lilly Co Eli Tricyclic steroid hormone nuclear receptor modulators
US7553867B2 (en) 2002-09-06 2009-06-30 Takeda Pharmaceutical Company Limited Furan or thiophene derivative and medicinal use thereof
WO2005012243A2 (en) 2003-08-01 2005-02-10 Janssen Pharmaceutica N.V. Substituted indole-o-glucosides
EP1734930A2 (en) * 2004-04-09 2006-12-27 Smithkline Beecham Corporation Low dose pharmaceutical products
US20090012133A1 (en) * 2006-01-10 2009-01-08 Smithkline Beecham Corporation Polymorphic Form of -Acetic Acid
WO2012168948A2 (en) * 2011-06-06 2012-12-13 Hetero Research Foundation Process for febuxostat

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69941777D1 (de) * 1998-03-10 2010-01-21 Ono Pharmaceutical Co Carbonsäurederivate und medikamente die diese als aktiven wirkstoff enthalten
PE20011010A1 (es) * 1999-12-02 2001-10-18 Glaxo Group Ltd Oxazoles y tiazoles sustituidos como agonista del receptor activado por el proliferador de peroxisomas humano
JP2004517100A (ja) * 2000-12-20 2004-06-10 グラクソ グループ リミテッド hPPARアルファアゴニストとしての置換オキサゾールおよびチアゾール
GB0111523D0 (en) * 2001-05-11 2001-07-04 Glaxo Group Ltd Chemical compounds
GB0113233D0 (en) * 2001-05-31 2001-07-25 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
WO2002096893A1 (en) 2002-12-05
ZA200308570B (en) 2005-02-03
DE60208682T2 (de) 2006-08-24
HUP0400117A3 (en) 2005-09-28
PL367114A1 (en) 2005-02-21
US7244849B2 (en) 2007-07-17
NO20035313L (no) 2003-12-09
IL158641A0 (en) 2004-05-12
US20040242657A1 (en) 2004-12-02
CO5540298A2 (es) 2005-07-29
CZ20033256A3 (en) 2004-04-14
NZ529486A (en) 2005-12-23
MXPA03010943A (es) 2004-02-27
JP2004532265A (ja) 2004-10-21
EP1395572B1 (en) 2006-01-11
CA2448101A1 (en) 2002-12-05
CN1551871A (zh) 2004-12-01
ES2256493T3 (es) 2006-07-16
DE60208682D1 (de) 2006-04-06
KR20040007631A (ko) 2004-01-24
NO20035313D0 (no) 2003-11-28
GB0113232D0 (en) 2001-07-25
EP1395572A1 (en) 2004-03-10
BR0209892A (pt) 2004-06-08
HUP0400117A2 (hu) 2005-03-29
AU2002317764B2 (en) 2005-01-06

Similar Documents

Publication Publication Date Title
DE602004005323D1 (de) Azidfreies verfahren zur herstellung von 1,2-diaminoverbindungen
CY1110631T1 (el) Διαλυτοποιημενα δηλητηρια τοποϊσομερασης
ATE425136T1 (de) Verfahren zur herstellung substituierter 3-aryl- butyl-aminverbindungen
JO2413B1 (en) Benzoxazine derivatives and their use
MXPA05005790A (es) Aminoalcoxiindoles como ligandos del receptor 5-ht6 para el tratamiento de enfermedades del sistema nervioso central.
ATE407127T1 (de) Verfahren zur herstellung von beraprost und dessen salzen
DE60208682D1 (de) Verfahren zur herstellung eines thiazol-ppar-liganden sowie dessen polymorphe
ATE241589T1 (de) Verfahren zur herstellung des neuraminidase- inhibitoren ro-64-0796
BR0209901A (pt) Processos para a sìntese de derivados de 2,3-dihidro-1,4-dioxino-[2,3-f] quinolina
DE60231426D1 (de) Solubilisierte topoisomerase-gift-mittel
ATE275149T1 (de) Verfahren zur herstellung von taxanderivaten
ATE339202T1 (de) Verwendung von alpha-halogenacryloyl-distamycin derivaten zur herstellung eines medikaments zur behandlung von krebs
ATE277887T1 (de) Verfahren zur herstellung von 1,4-bis((2- (dimethylamino)ethyl amino)-5,8- dihydroxyanthracene-9,10-dion
DE60224884D1 (de) Verfahren zur herstellung von 3, 3', 6, 6'-tetraalkylen-2, 2'-biphenolen und 3, 3', 6, 6'-tetraalkylen-5, 5'-dihalo-2, 2' biphenolen
ATE496038T1 (de) Verfahren zur herstellung von quetiapin
SG149005A1 (en) Process for the preparation of thiazolopyrimidines
DE60106778D1 (de) Verfahren zur herstellung von vitronectin-rezeptorantagonisten
WO2007014839A3 (en) Cathepsin k inhibitors
DE60107292D1 (de) Verfahren zur herstellung von (+)-trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidin
ATE447563T1 (de) Verfahren zur herstellung eines immunosuppresivums
ATE250597T1 (de) N-benzolsulfonyl-l-prolin derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung
ATE173259T1 (de) Verfahren zur herstellung von indolizinderivaten
ATE330612T1 (de) Verfahren zur herstellung von benazeprilhydrochloride
ATE466847T1 (de) Verfahren zur herstellung von 14-beta- hydroxybaccatin-iii-1,14-carbonat
ATE297478T1 (de) Verfahren zur herstellung von orthocarbonsäuretrialkylestern

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties